Bibliography

Export 29 results:
Filters: Keyword is Survival Analysis  [Clear All Filters]
2013
Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood//Blood. 2013;121(6):1059-64.
2007
Jimenez C, Manrique A, Marques E, Ortega P, Loinaz C, Gomez R, et al. Incidence and risk factors for the development of lung tumors after liver transplantation. Transpl Int. 2007;20(1):57-63.
2006
Tevar AD, Succop P, Schneider CR, Thambi-Pillai T, Thomas MJ, Neff G, et al. Liver transplantation for primary and metastatic hepatic malignancy: a single center experience. Surgery. 2006;139(4):535-41.
Husted TL, Neff G, Thomas MJ, Gross TG, Woodle ES, Buell JF. Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant. 2006;6(2):392-7.
2005
Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
Buell JF, Gross T, Alloway RR, Trofe J, Woodle ES. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc. 2005;37(2):583-4.
Buell JF, Gross TG, Hanaway MJ, Trofe J, Muthiak C, First MR, et al. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc. 2005;37(2):960-1.
Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla FJ, Wiesel M. EAU guidelines on renal transplantation. Eur Urol. 2005;47(2):156-66.
Woodle ES, Susskind B, Alloway RR, Hanaway MJ, Thomas M, Buell J, et al. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc. 2005;37(2):809-11.
Schneider CR, Buell JF, Gearhart M, Thomas M, Hanaway MJ, Rudich SM, et al. Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc. 2005;37(2):1243-4.
Woodle ES, Gupta M, Buell JF, Neff GW, Gross TG, First MR, et al. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
2004
Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J, et al. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum. 2004;47(11):1898-903.
Chui AK, Rao AR, Island ER, Chan HL, Leung TW, Lau WY. Multimodality tumor control and living donor transplantation for unresectable hepatocellular carcinoma. Transplant Proc. 2004;36(8):2287-8.
2003
Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenburg A, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion. 2003;43(8):1153-61.
Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation. 2003;76(9):1289-93.
2002
Buell JF, Husted T, Hanaway MJ, Peddi VR, Trofe J, Gross TG, et al. Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.
Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion. 2002;42(10):1293-301.
2001
Borderie VM, Sabolic V, Touzeau O, Scheer S, Carvajal-Gonzalez S, Laroche L. Screening human donor corneas during organ culture for the presence of guttae. Br J Ophthalmol. 2001;85(3):272-6.
Satoi S, Bramhall SR, Solomon M, Hastings M, Mayer AD, de Goyet JV, et al. The use of liver grafts from donors with bacterial meningitis. Transplantation. 2001;72(6):1108-13.
2000
Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69(8):1633-7.
1999
Chui AK, Rao AR, McCaughan GW, Waugh R, Verran DJ, Koorey D, et al. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Aust N Z J Surg. 1999;69(11):798-801.
Freeman RB, Giatras I, Falagas ME, Supran S, O'Connor K, Bradley J, et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation. 1999;68(8):1107-11.
Shapiro R, Nalesnik MA, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999;68(12):1851-4.
1997
Cosgriff N, Moore E, Sauaia A, Kenny-Moynihan M, Burch J, Galloway B. Predicting Life-threatening Coagulopathy in the Massively Transfused Trauma Patient: Hypothermia and Acidoses Revisited. //J Trauma. 1997;42(5):857-862.

Pages